Portfolio company
Alzeca Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pre Diagnostics
This company develops intracellular blood tests and biomarker analytical services for the early detection of Alzheimer's disease for patients, practitioners and researchers.
Cajal Neuroscience
This biotechnology company develops drug discovery platforms and therapeutics for neurodegenerative diseases to assist healthcare providers and patients.
Muna Therapeutics
This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.
Promental Health
Promental Health develops a blood test using microRNA biomarkers and machine learning for the early diagnosis of Alzheimer's disease for healthcare providers.
Monument Biosciences
This biotechnology company develops disease-modifying drugs and translational biomarkers to treat Alzheimer's disease and related dementias.
Altoida
This company develops an augmented reality platform to assess cognitive function and detect Alzheimer's disease for healthcare providers and clinical researchers.
Cytox
This company develops non-invasive genetic tests for Alzheimer's disease risk assessment and patient stratification for clinicians and pharmaceutical researchers.
Banyan Biomarkers
This company develops blood tests to detect mild traumatic brain injuries for healthcare providers and clinical diagnostic laboratories.
